about
Idiotype vaccination for Non-Hodgkin lymphomaIdiotype vaccination for Non-Hodgkin lymphomaLiposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigenRecent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomesHigh-efficiency screening of monoclonal antibodies for membrane protein crystallographyInduction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.Adjuvants for vaccines to drugs of abuse and addiction.The use of live attenuated bacteria as a delivery system for heterologous antigens.Liposomes as protein carriers in immunology.Design opportunities for actively targeted nanoparticle vaccines.Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature.Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancerLiposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.
P2860
Q24186272-7680840E-E861-4C83-98AA-DA85F6BB6269Q24235281-3E91E16C-197F-4AEA-834E-67873614E015Q33755289-259EC86A-186A-424E-91D4-72E097A544DAQ33959996-77BCCEF5-2F0B-44D5-8C3D-3739CC39BD16Q34023852-3CF98817-82DF-44BA-902A-735C9E4D390CQ34345308-D6E2AF77-4907-4B8B-8E5B-21CD4302E199Q35493923-F259024F-BC11-4DE9-9670-BD2648656759Q35809240-03878740-2A1E-475E-8B54-D02F8F1BDB9EQ36022235-4F2E99A4-D523-4283-B3E5-B3DCE349ECAFQ37062606-F69D92EC-1E1E-46FA-962D-879C018290B4Q37142202-B400CFA9-5E1F-439E-9458-F1D2293D2236Q37247915-D98FFFB8-853B-4E1D-9E5A-2BC1BB048D10Q37851520-C4DD35B9-BA89-4B72-BC36-0DB0018F6F18Q38162231-9694121C-3D17-4153-99AE-712191E33C21Q38281731-298B20CD-03A3-48CE-8573-4A8A937CB1D3Q40433315-55B15EBB-707B-4369-AA30-392DE4C23284Q46441250-0CE207A5-1257-4981-BA17-4E74D5A0E2C6Q46781197-04C435E5-4C63-42DB-B805-2E5B2D82782B
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Liposomes as carriers for vaccines.
@en
type
label
Liposomes as carriers for vaccines.
@en
prefLabel
Liposomes as carriers for vaccines.
@en
P2093
P356
P1433
P1476
Liposomes as carriers for vaccines.
@en
P2093
C R Alving
N M Wassef
R L Richards
P304
P356
10.1006/IMMU.1994.1023
P577
1994-06-01T00:00:00Z